Dicerna Pharmaceuticals Inc (DRNA)
Common Stock
| MRQ (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 165.76M | 126.00M | 152.80M | 54.20M | 68.80M | |||
| Marketable Securities | 399.75M | 442.80M | 196.10M | 248.40M | 44.90M | |||
| Receivables | 6.23M | 36.10M | 202.10M | 100.80M | 1.60M | |||
| Other Current Assets | 17.27M | 13.80M | 5.20M | 2.10M | 3.40M | |||
| Total Current Assets | 589.00M | 618.70M | 556.20M | 405.50M | 118.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 94.53M | 78.40M | 37.20M | 2.70M | 1.50M | |||
| Investments And Advances | 81.08M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 7.44M | 10.80M | 4.10M | 800.00K | 800.00K | |||
| Total Non-Current Assets | 183.06M | 89.10M | 41.20M | 3.50M | 2.30M | |||
| TOTAL ASSETS | 772.06M | 707.80M | 597.40M | 409.00M | 121.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 39.02M | 31.50M | 23.40M | 20.10M | 5.70M | |||
| Accounts Payable | 8.32M | 7.90M | 6.10M | 5.00M | 4.90M | |||
| Other Current Liabilities | 191.96M | 138.50M | 212.30M | 68.90M | 6.20M | |||
| Total Current Liabilities | 239.29M | 177.90M | 241.70M | 94.10M | 16.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 425.10M | 392.20M | 203.50M | 114.30M | 3.10M | |||
| Total Non-Current Liabilities | 425.10M | 392.20M | 203.50M | 114.20M | 3.10M | |||
| TOTAL LIABILITIES | 664.40M | 570.10M | 445.20M | 208.30M | 19.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -725.91M | -638.10M | -525.30M | -404.80M | -316.00M | |||
| Additional Paid In Capital | 833.57M | 775.80M | 677.50M | 605.50M | 417.00M | |||
| Common Shares | 8.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 77.83M | 75.80M | 71.60M | 68.20M | 51.60M | |||
| Tangible Book Value per Share | 1.38 | 1.82 | 2.13 | 2.94 | 1.96 | |||
| Total Shareholders' Equity | 107.66M | 137.80M | 152.20M | 200.70M | 101.10M | |||
| TOTAL LIABILITIES AND EQUITY | 772.06M | 707.80M | 597.40M | 409.00M | 121.00M | |||
| Statistics | ||||||||
| Current Ratio | 2.46 | 3.48 | 2.30 | 4.31 | 7.07 | |||
| Return On Assets (ROA) | -16.12% | -15.92% | -20.17% | -21.74% | -49.75% | |||
| Return On Equity (ROE) | -115.59% | -81.79% | -79.17% | -44.29% | -59.55% | |||
All data in USD